Fig. 1

Differential expression and survival analysis of hsa-miR-320a-3p in STAD. Expression boxplot of hsa-miR-320a-3p comparing tumor and normal tissue by Mir-TV (A). Differentially expressed miR-320a-3p in STAD based on individual cancer stages (B), tumor histology (C), tumor grade (D), and nodal metastasis status (E) using UALCAL. Survival analysis of hsa-miR-320a in gastric patients (F) by ESOMIR (*P value < 0.05, **P value < 0.01, ***P value < 0.001, and ****P value < 0.0001).